| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/17/2023 | 13.3% | Morgan Stanley | $40 → $38 | Maintains | Overweight |
| 07/17/2023 | 19.26% | Morgan Stanley | $42 → $40 | Maintains | Overweight |
| 06/29/2023 | 24.63% | Jefferies | → $41.8 | Initiates Coverage On | → Buy |
| 06/14/2023 | 25.22% | Morgan Stanley | → $42 | Reiterates | Overweight → Overweight |
| 05/01/2023 | 31.19% | Piper Sandler | $49 → $44 | Maintains | Overweight |
| 05/01/2023 | 25.22% | Morgan Stanley | $40 → $42 | Maintains | Overweight |
| 04/18/2023 | 19.26% | Morgan Stanley | $44 → $40 | Maintains | Overweight |
| 02/21/2023 | 31.19% | Morgan Stanley | $42 → $44 | Maintains | Overweight |
| 01/04/2023 | 25.22% | Morgan Stanley | $35 → $42 | Maintains | Overweight |
| 11/18/2022 | 34.17% | Piper Sandler | $33 → $45 | Maintains | Overweight |
| 11/15/2022 | 49.08% | JP Morgan | $45 → $50 | Maintains | Overweight |
| 10/13/2022 | 13.3% | Stifel | $30 → $38 | Upgrades | Hold → Buy |
| 07/13/2022 | 4.35% | Morgan Stanley | $40 → $35 | Maintains | Overweight |
| 07/07/2022 | 37.15% | Jefferies | $35.7 → $46 | Upgrades | Hold → Buy |
| 05/09/2022 | 25.22% | Barclays | $32 → $42 | Maintains | Overweight |
| 04/11/2022 | 13.3% | Morgan Stanley | $32 → $38 | Maintains | Overweight |
| 03/14/2022 | 28.21% | Wolfe Research | $38 → $43 | Upgrades | Underperform → Peer Perform |
| 02/28/2022 | -4.59% | Barclays | $27 → $32 | Upgrades | Equal-Weight → Overweight |
| 02/18/2022 | -4.59% | Morgan Stanley | $30 → $32 | Maintains | Overweight |
| 12/07/2021 | -19.5% | Barclays | $26 → $27 | Maintains | Equal-Weight |
| 11/08/2021 | -1.61% | JP Morgan | $23 → $33 | Upgrades | Neutral → Overweight |
| 08/26/2021 | -22.48% | Barclays | $25 → $26 | Maintains | Equal-Weight |
| 07/09/2021 | -16.52% | Morgan Stanley | $25 → $28 | Maintains | Overweight |
| 04/30/2021 | -25.46% | Morgan Stanley | $23 → $25 | Maintains | Overweight |
| 03/10/2021 | -25.46% | Barclays | $15 → $25 | Upgrades | Underweight → Equal-Weight |
| 03/02/2021 | — | Exane BNP Paribas | Upgrades | Underperform → Neutral | |
| 02/26/2021 | -31.43% | Morgan Stanley | $19 → $23 | Maintains | Overweight |
| 01/26/2021 | -56.77% | Goldman Sachs | → $14.5 | Downgrades | Buy → Neutral |
| 11/24/2020 | -44.84% | B of A Securities | → $18.5 | Upgrades | Neutral → Buy |
| 11/20/2020 | -52.3% | Stifel | → $16 | Downgrades | Buy → Hold |
| 10/07/2020 | -59.75% | Piper Sandler | $15 → $13.5 | Maintains | Neutral |
| 09/16/2020 | -52.3% | Scotiabank | → $16 | Initiates Coverage On | → Sector Outperform |
| 09/15/2020 | -57.07% | B of A Securities | $16.2 → $14.4 | Maintains | Neutral |
| 08/07/2020 | -55.28% | Morgan Stanley | $16 → $15 | Maintains | Overweight |
| 06/16/2020 | -55.28% | Piper Sandler | $12.2 → $15 | Maintains | Neutral |
| 05/04/2020 | -55.28% | Barclays | $13 → $15 | Maintains | Equal-Weight |
| 05/04/2020 | -56.11% | Jefferies | $16.68 → $14.72 | Downgrades | Buy → Hold |
| 05/01/2020 | -49.31% | Stifel | $16 → $17 | Maintains | Buy |
| 04/07/2020 | -56.77% | Piper Sandler | $13.5 → $14.5 | Maintains | Neutral |
| 04/01/2020 | -52.3% | Stifel | $20 → $16 | Maintains | Buy |
| 03/16/2020 | -52.3% | Morgan Stanley | $25 → $16 | Upgrades | Equal-Weight → Overweight |
| 01/14/2020 | — | Bernstein | Initiates Coverage On | → Outperform | |
| 10/08/2019 | -13.54% | Morgan Stanley | $33 → $29 | Maintains | Overweight |
| 08/02/2019 | -1.61% | Stifel | $35 → $33 | Maintains | Buy |
| 03/26/2019 | — | Goldman Sachs | Downgrades | Neutral → Sell | |
| 01/18/2019 | — | Citigroup | Upgrades | Neutral → Buy | |
| 12/07/2018 | -22.48% | UBS | $40 → $26 | Maintains | Neutral |
What is the target price for Tenaris (TS)?
The latest price target for Tenaris (NYSE: TS) was reported by Morgan Stanley on October 17, 2023. The analyst firm set a price target for $38.00 expecting TS to rise to within 12 months (a possible 13.30% upside). 11 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tenaris (TS)?
The latest analyst rating for Tenaris (NYSE: TS) was provided by Morgan Stanley, and Tenaris maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Tenaris (TS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tenaris, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tenaris was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.
Is the Analyst Rating Tenaris (TS) correct?
While ratings are subjective and will change, the latest Tenaris (TS) rating was a maintained with a price target of $40.00 to $38.00. The current price Tenaris (TS) is trading at is $33.54, which is out of the analyst's predicted range.